ARK Investment Management’s Ginkgo Bioworks DNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-596,280	Closed	-$7.97M	–	189
2024 Q2	$7.97M	Sell	596,280 -4,143,893	-87%	-$124M	0.07%	103
2024 Q1	$220M	Sell	4,740,173 -224,992	-5%	-$11.6M	1.52%	21
2023 Q4	$336M	Buy	4,965,165 +410,360	+9%	+$25.1M	1.99%	18
2023 Q3	$330M	Buy	4,554,805 +311,067	+7%	+$24.9M	2.52%	14
2023 Q2	$316M	Buy	4,243,738 +124,813	+3%	+$7.39M	2.09%	18
2023 Q1	$219M	Buy	4,118,925 +509,323	+14%	+$32.3M	1.51%	21
2022 Q4	$244M	Buy	3,609,602 +439,131	+14%	+$40.4M	2.11%	17
2022 Q3	$396M	Buy	3,170,471 +986,520	+45%	+$118M	2.76%	13
2022 Q2	$269M	Buy	2,183,951 +570,610	+35%	+$69.6M	1.6%	18
2022 Q1	$260M	Buy	1,613,341 +533,820	+49%	+$104M	1.09%	23
2021 Q4	$359M	Buy	1,079,521 +498,750	+86%	+$237M	1.09%	27
2021 Q3	$269M	Buy	+580,771	New	+$283M	0.65%	39